home > news > detailed info

SCHOTT Pharmaversity – Sharing expertise. Shaping tomorrow

Schott AG

Global pharma specialist in primary packaging SCHOTT launches a new service for the entire pharmaceutical industry. SCHOTT founded the Pharmaversity, an inspirational network hub for experts in the industry, provided by experts in glass and polymer. This is in line with SCHOTT’s mind-set to strongly focus on collaborative aspects as a key business driver and to share knowledge among the key players in the industry to move it forward together.

Times like these need new approaches and ideas to share knowledge and gain insights on primary packaging. For this reason, SCHOTT decided to launch a new digital format in terms of a full academic, educational and scientific program for the pharmaceutical industry to keep up with the pace in the drug development pipeline. “We need to support our customers in the current and forthcoming projects, no matter if it’s vaccines against COVID-19 or other new biologics. Tradeshows and conference as one of the important place to meet and discuss have been mostly postponed or cancelled. That’s why we developed a format to introduce our innovations and new topics to our customers,” says Björn Weller, Head of Marketing at SCHOTT Pharmaceutical Systems.

The digital Pharmaversity addresses all functional levels within pharmaceutical companies, CMO, CDMO and all small to big-sized biotech companies. The program consists of 15 topics spread across 12 weeks. The topics reflect SCHOTT’s current product portfolio and cover all products from glass primary packaging and polymer solutions to ready-to-use, sterile insights. It offers exclusive scientific insights and will invite the audience for a deeper learning path adapted to the specific needs of each and individual drug to be developed after the webinar. Each session lasts 30 minutes followed by additional time for questions and answers. For each topic, SCHOTT creates an interesting podcast with the responsible product expert who shares background knowledge and a deeper understanding of the topic itself.

SCHOTT offers this service free of charge for its customers and partners. The full line up of each session with the content summary and the registration process can be accessed via the website

This new digital service of the Pharmaversity starts now and will be extended to feature more digital formats in the near future. Nevertheless, there is more to come also in the “offline” world and the SCHOTT Pharmaversity will make its mark in the pharmaceutical networking world with scientific-based and data-driven sessions.

Learn more at

SCHOTT is a leading international technology group in the areas of specialty glass, glass-ceramics and related high-tech materials. With over 130 years of experience, the company is an innovative partner to many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT has a global presence with production sites and sales offices in 34 countries. In the 2018/2019 fiscal year, the group generated sales of EUR 2.2 billion with over 16,200 employees. SCHOTT AG has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. This is one of the oldest private and largest science-promoting foundations in Germany. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.
phone +44 (0)1785 223166
email Drummond Road ST16 3EL Stafford United Kingdom
Print this page
Send to a friend
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development


As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement